Immune Pharmaceuticals

Immune Pharmaceuticals Inc. NASDAQ OMX First North Premier IMNP; OTCQX IMNP, applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Companys lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohns disease and severe asthma. The Company is evaluating the

OVERVIEW

This web site immunepharma.com presently has a traffic ranking of zero (the lower the more users). We have probed zero pages inside the web site immunepharma.com and found four websites referring to immunepharma.com. We were able to note one contacts and addresses for immunepharma.com to help you contact them. We were able to note three social media sites possessed by immunepharma.com. This web site immunepharma.com has been online for seven hundred and eighty-four weeks, fifteen days, two hours, and fifteen minutes.
Links to this site
4
Contacts
1
Locations
1
Social Links
3
Online Since
Jun 2009

IMMUNEPHARMA.COM RANKINGS

This web site immunepharma.com is seeing a fluctuation quantities of traffic through the year.
Traffic for immunepharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for immunepharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for immunepharma.com

Date Range

All time
This Year
Last Year
Last Month

IMMUNEPHARMA.COM HISTORY

This web site immunepharma.com was first documented on June 20, 2009. It will expire on the date of June 20, 2015. It is now seven hundred and eighty-four weeks, fifteen days, two hours, and fifteen minutes young.
REGISTERED
June
2009
EXPIRED
June
2015

WEB PAGE PERIOD OF EXISTANCE

15
YEARS
0
MONTHS
14
DAYS

LINKS TO WEB SITE

StockGoodies Plays of the Week A Community Of Stock Traders

A Community Of Stock Traders. Agora Holdings is a holding company with interests in the media and software applications. Through its wholly-owned subsidiary, Geegle Media, Agora is dedicated to deliver media products to fulfill the growing needs for social, TV on Demand, data storage applications and other optimizing software solutions. A customized experience, .

WHAT DOES IMMUNEPHARMA.COM LOOK LIKE?

Desktop Screenshot of immunepharma.com Mobile Screenshot of immunepharma.com Tablet Screenshot of immunepharma.com

CONTACTS

Immune Pharmaceuticals

Danit Shema

11 Galgale Haplada

Herzliya, Herzlya, 46722

ISRAEL

IMMUNEPHARMA.COM HOST

Our parsers revealed that a lone page on immunepharma.com took five hundred and eighty milliseconds to load. I could not observe a SSL certificate, so therefore we consider this site not secure.
Load time
0.58 secs
SSL
NOT SECURE
Internet Protocol
23.185.0.2

NAME SERVERS

ns69.domaincontrol.com
ns70.domaincontrol.com

WEBSITE IMAGE

SERVER OS AND ENCODING

I revealed that immunepharma.com is operating the nginx server.

PAGE TITLE

Immune Pharmaceuticals

DESCRIPTION

Immune Pharmaceuticals Inc. NASDAQ OMX First North Premier IMNP; OTCQX IMNP, applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Companys lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohns disease and severe asthma. The Company is evaluating the

CONTENT

This web site had the following on the web site, "Is a member of the Crohns and Colitis Foundation of America CCFA Presidents Corporate Circle." We noticed that the web site said " PRESS RELEASE March 12, 2018." It also said " Immune Pharmaceuticals Announces Acceptance of Abstract at 2018 Pre-IID Pemphigus and Pemphigoid Symposium Read more. PRESS RELEASE February 27, 2018. Immune Pharmaceuticals Announces Outcome of Annual Meeting of Stockholders Read more. PRESS RELEASE February 20, 2018." The header had IMMUNE Pharmaceuticals as the highest ranking optimized keyword.

VIEW SIMILAR BUSINESSES

Immune Power Health Blog

Sunday, April 25, 2010. Later in my blog I will tell you the amazing story of how I got my name, but I will share some equally amazing stories before. Please feel free to share this site with others that you think might be blessed by reading the E Book and the blog. God bless and keep you. If it were my regular chiropractor, he would have known that there was something wrong immedi.

ImmuneQuest

Users having trouble running ImmuneQuest, go HERE. Is an innovative educational game for college students that brings immunology to life. A New Way to Learn Immunology. Advanced Learning Methodology Learn by Doing. This material is based upon work s.

Alternative Cancer Treatments Immune Recovery Centers of America

In conventional cancer treatments, the body is bombarded with a large dose of toxicity drugs and often radiation. This method harms the immune system, which makes it difficult to truly deliver a cancer cure. We take an alternative and integrative approach to cancer care. Our treatments are individualized to each person. Washington, DC, Clinic. To arrange a Free Telephone Consultation with an. IPT and Chemotherapy of Cancer. Chemo agents are very unpopular with the majority o.

immuneregulation.com

Il a été enregistré via gandi. More information about the owner. Enregistrer votre nom de domaine. Rechercher un nom de domaine. It is currently being parked by the owner.

Home - Immune Regulation News

Immunology of Infectious Disease News. The Immune Regulation Research Community. A Dominant Role for Regulatory T Cells in Protecting Females against Pulmonary Hypertension. Investigators evaluated whether and how Treg-deficiency differentially affects male and female rats in experimental pulmonary arterial hypertension.